EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Defining and targeting tumor-associated macrophages in malignant mesothelioma

Licun Wu iD, Mikihiro Kohno iD, Junichi Murakami, Amin Zia iD, Jonathan Allen, Hana Yun, Meilin Chan iD, Cristina Baciu iD, Mingyao Liu, Veronique Serre-Beinier iD, Michele De Palma iD, Emanuela Felley-Bosco iD und 3 weitere

Proceedings of the National Academy of Sciences · 28.02.2023 · 120 (9)

DOI: 10.1073/pnas.2210836120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.02.2023. Verfasst von Licun Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Latner Thoracic Surgery Research Laboratories, Division of Thoracic Surgery, Toronto General Hospital, Toronto General Hospital Research Institute, U…. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Mesothelioma. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Princess Margaret Cancer Foundation (PMCF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defining the ontogeny of tumor-associated macrophages (TAM) is important to develop therapeutic targets for mesothelioma. We identified two distinct macrophage populations in mouse peritoneal and pleural cavities, the monocyte-derived, small peritoneal/pleural macrophages (SPM), and the tissue-resident large peritoneal/pleural macrophages (LPM). SPM rapidly increased in tumor microenvironment after tumor challenge and contributed to the vast majority of M2-like TAM. The selective depletion of M2-like TAM by conditional deletion of the Dicer1 gene in myeloid cells (D −/− ) promoted tumor rejection. Sorted SPM M2-like TAM initiated tumorigenesis in vivo and in vitro, confirming their capacity to support tumor development. The transcriptomic and single-cell RNA sequencing analysis demonstrated that both SPM and LPM contributed to the tumor microenvironment by promoting the IL-2-STAT5 signaling pathway, inflammation, and epithelial–mesenchymal transition. However, while SPM preferentially activated the KRAS and TNF-α/NFkB signaling pathways, LPM activated the IFN-γ response. The importance of LPM in the immune response was confirmed by depleting LPM with intrapleural clodronate liposomes, which abrogated the antitumoral memory immunity. SPM gene signature could be identified in pleural effusion and tumor from patients with untreated mesothelioma. Five genes, TREM2, STAB1, LAIR1, GPNMB , and MARCO , could potentially be specific therapeutic targets. Accordingly, Trem2 gene deletion led to reduced SPM M2-like TAM with compensatory increase in LPM and slower tumor growth. Overall, these experiments demonstrate that SPM M2-like TAM play a key role in mesothelioma development, while LPM more specifically contribute to the immune response. Therefore, selective targeting of monocyte-derived TAM may enhance antitumor immunity through compensatory expansion of tissue-resident TAM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesothelioma, MalignantMesotheliomaAnimalsMiceTumor-Associated MacrophagesMacrophagesMonocytesTumor MicroenvironmentMembrane GlycoproteinsReceptors, ImmunologicCell Adhesion Molecules, Neuronal

Stichwörter der Autor:innen

cancergene signaturemesotheliomatumor microenvironmenttumor-associated macrophages

Substanzen

Trem2 protein, mouseMembrane GlycoproteinsReceptors, ImmunologicStab1 protein, mouseCell Adhesion Molecules, Neuronal

Autor:innen und Institutionen

  • Latner Thoracic Surgery Research Laboratories, Division of Thoracic Surgery, Toronto General Hospital, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, ON M5G 1L7,…
  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • dYcode Inc., Toronto, ON L6C 2R9, Canada.
  • Department of Thoracic Surgery, University Hospitals of Geneva, Geneva 1205, Switzerland.
  • Swiss Federal Institute of Technology in Lausanne (Ecole Polytechnique Fédérale de Lausanne), Lausanne 1015, Switzerland.
  • Agora Research Cancer Centre, Lausanne 1005, Switzerland.

ORCID-Profile: Licun Wu, Mikihiro Kohno, Amin Zia, Meilin Chan, Cristina Baciu, Veronique Serre-Beinier, Michele De Palma, Emanuela Felley-Bosco

Förderung

  • Princess Margaret Cancer Foundation (PMCF)

Zitieren

APA

Wu, L., Kohno, M., Murakami, J., Zia, A., Allen, J., Yun, H., Chan, M., Baciu, C., Liu, M., Serre-Beinier, V., De Palma, M., Felley-Bosco, E., Yeung, J., Pugh, T. J., & de Perrot, M. (2023). Defining and targeting tumor-associated macrophages in malignant mesothelioma. Proceedings of the National Academy of Sciences, 120(9). https://doi.org/10.1073/pnas.2210836120

Vancouver

Wu L, Kohno M, Murakami J, Zia A, Allen J, Yun H, et al. Defining and targeting tumor-associated macrophages in malignant mesothelioma. Proceedings of the National Academy of Sciences. 2023;120(9). doi:10.1073/pnas.2210836120

BibTeX
@article{Wu2023,
  author = {Wu, Licun and Kohno, Mikihiro and Murakami, Junichi and Zia, Amin and Allen, Jonathan and Yun, Hana and Chan, Meilin and Baciu, Cristina and Liu, Mingyao and Serre-Beinier, Veronique and De Palma, Michele and Felley-Bosco, Emanuela and Yeung, Jonathan and Pugh, Trevor J and de Perrot, Marc},
  title = {Defining and targeting tumor-associated macrophages in malignant mesothelioma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {9},
  doi = {10.1073/pnas.2210836120}
}
Kostenlos starten →